Page last updated: 2024-08-23

fenoxycarb and Stomach Neoplasms

fenoxycarb has been researched along with Stomach Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gong, Y; Li, GF; Yu, G1
Chu, MP; Sawyer, MB1
Gu, W; Shan, B; Wang, L1
Hussaarts, KGAM; Mathijssen, RHJ; van Leeuwen, RWF1

Other Studies

4 other study(ies) available for fenoxycarb and Stomach Neoplasms

ArticleYear
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.
    JAMA oncology, 2018, 02-01, Volume: 4, Issue:2

    Topics: Capecitabine; Esophageal Neoplasms; Humans; Logic; Proton Pump Inhibitors; Stomach Neoplasms

2018
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer-Reply.
    JAMA oncology, 2018, 02-01, Volume: 4, Issue:2

    Topics: Capecitabine; Esophageal Neoplasms; Humans; Logic; Proton Pump Inhibitors; Stomach Neoplasms

2018
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.
    JAMA oncology, 2018, 02-01, Volume: 4, Issue:2

    Topics: Capecitabine; Esophageal Neoplasms; Humans; Logic; Proton Pump Inhibitors; Stomach Neoplasms

2018
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.
    JAMA oncology, 2018, 02-01, Volume: 4, Issue:2

    Topics: Capecitabine; Esophageal Neoplasms; Humans; Logic; Proton Pump Inhibitors; Stomach Neoplasms

2018